Editorial: sulfonylureas differ in effects on ischemic preconditioning--is it time to retire glyburide?
Riddle
Matthew C
MC
D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005905:Glyburide / Q000009:adverse effects*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D019194:Ischemic Preconditioning; D013453:Sulfonylurea Compounds / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D005905:Glyburide